Literature DB >> 17999957

The mechanism of human nonhomologous DNA end joining.

Michael R Lieber1.   

Abstract

Double-strand breaks are common in all living cells, and there are two major pathways for their repair. In eukaryotes, homologous recombination is restricted to late S or G(2), whereas nonhomologous DNA end joining (NHEJ) can occur throughout the cell cycle and is the major pathway for the repair of double-strand breaks in multicellular eukaryotes. NHEJ is distinctive for the flexibility of the nuclease, polymerase, and ligase activities that are used. This flexibility permits NHEJ to function on the wide range of possible substrate configurations that can arise when double-strand breaks occur, particularly at sites of oxidative damage or ionizing radiation. NHEJ does not return the local DNA to its original sequence, thus accounting for the wide range of end results. Part of this heterogeneity arises from the diversity of the DNA ends, but much of it arises from the many alternative ways in which the nuclease, polymerases, and ligase can act during NHEJ. Physiologic double-strand break processes make use of the imprecision of NHEJ in generating antigen receptor diversity. Pathologically, the imprecision of NHEJ contributes to genome mutations that arise over time.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999957     DOI: 10.1074/jbc.R700039200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  293 in total

1.  GJB1/Connexin 32 whole gene deletions in patients with X-linked Charcot-Marie-Tooth disease.

Authors:  Claudia Gonzaga-Jauregui; Feng Zhang; Charles F Towne; Sat Dev Batish; James R Lupski
Journal:  Neurogenetics       Date:  2010-06-09       Impact factor: 2.660

Review 2.  Microdeletion and microduplication syndromes.

Authors:  Anja Weise; Kristin Mrasek; Elisabeth Klein; Milene Mulatinho; Juan C Llerena; David Hardekopf; Sona Pekova; Samarth Bhatt; Nadezda Kosyakova; Thomas Liehr
Journal:  J Histochem Cytochem       Date:  2012-03-06       Impact factor: 2.479

Review 3.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

4.  Genomic instability in chronic myeloid leukemia: targets for therapy?

Authors:  N Muvarak; P Nagaria; F V Rassool
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

5.  Putative binding modes of Ku70-SAP domain with double strand DNA: a molecular modeling study.

Authors:  Shaowen Hu; Janice M Pluth; Francis A Cucinotta
Journal:  J Mol Model       Date:  2011-09-27       Impact factor: 1.810

6.  Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism.

Authors:  Sheetal Sharma; Bibha Choudhary; Sathees C Raghavan
Journal:  Cell Mol Life Sci       Date:  2010-08-03       Impact factor: 9.261

7.  Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells.

Authors:  Tadi Satish Kumar; Vijayalakshmi Kari; Bibha Choudhary; Mridula Nambiar; T S Akila; Sathees C Raghavan
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

Review 8.  Coordination of DNA-PK activation and nuclease processing of DNA termini in NHEJ.

Authors:  Katherine S Pawelczak; Sara M Bennett; John J Turchi
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

9.  DNA-PKcs regulates a single-stranded DNA endonuclease activity of Artemis.

Authors:  Jiafeng Gu; Sicong Li; Xiaoshan Zhang; Ling-Chi Wang; Doris Niewolik; Klaus Schwarz; Randy J Legerski; Ebrahim Zandi; Michael R Lieber
Journal:  DNA Repair (Amst)       Date:  2010-02-01

10.  Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects.

Authors:  Lubomir Balabanski; Georgi Antov; Ivanka Dimova; Samuil Ivanov; Maria Nacheva; Ivan Gavrilov; Desislava Nesheva; Blaga Rukova; Savina Hadjidekova; Maxim Malinov; Draga Toncheva
Journal:  Mol Clin Oncol       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.